FDA approves generic cardiovascular drug

Actavis' generic version of Valeant's Tiazac approved

MORRISTOWN, N.J. — The Food and Drug Administration has approved a generic drug for treating blood pressure and chest pain.

Actavis announced Wednesday the approval of diltiazem hydrochloride extended-release capsules.

The drug is a generic version of Valeant's Tiazac. The branded drug and its generic equivalents had sales of about $76.3 million in 2011, according to IMS Health.


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Recommended stories

Login or Register to post a comment.